Professor

Kristofer Thurecht

Email: 

Background

Professor Kris Thurecht has appointments at AIBN and UQ’s Centre for Advanced Imaging where he is the Deputy Director of Imaging Technologies. Professor Thurecht has been recognised for scientific excellence with a 2012 Queensland Young Tall Poppy Science Award and a 2010 UQ Foundation Research Excellence Award for his work in developing polymer ‘theranostics’. In 2015 he was recognised by the Royal Australian Chemical Institute Polymer Division through award of the David Sangster Polymer Science and Technology Award for scientific excellence for a mid-career researcher. Since obtaining his PhD in 2005, he has been the recipient of five competitive national and international fellowships, the latest being an NHMRC CDF, and prior to that award an ARC Future Fellowship. He has contributed scientific and review articles to various leading journals in his field, including invited articles in the Emerging Young Investigator issue of Chemical Communications and a Young Talent article in Macromolecular Chemistry and Physics. Professor Thurecht has been chief investigator on grants from various funding bodies, including ARC Discovery grants; ARC Linkage Grants, with both national and international companies; National Health and Medical Research Council (NHMRC) grants; and funding from various cancer foundations. He is co-inventor on 8 patents. He is CI on the ARC Training Centre for Innovation in BioMedical Imaging Technology in which he is theme leader, and is Director of the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals.

Availability

Professor Kristofer Thurecht is:
Available for supervision
Media expert

Fields of research

Macromolecular and materials chemistry

Qualifications

  • Bachelor of Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research impacts

Research

Design and synthesis of architectural polymers applied to molecular imaging and drug delivery in nanomedicine. In collaboration with industry, Prof Thurecht's research has contributed to development and translation of new agents for detection and treatment of cancer.

Search Professor Kristofer Thurecht’s works on UQ eSpace

249 works between 2002 and 2025
All (249) Journal Article (211) Book Chapter (5) Conference Publication (31) Other Outputs (2)

21 - 40 of 249 works

2023

Journal Article

Abstract A147: a HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging

Johnstone, Cameron N., Heery, Graham P., Kelly, Brian D, Humphries, James, Akhter, Dewan T., Thurecht, Kristofer J., Yuen, Daniel, Giannis, Michael, Yong, Ken, Chadwick, Gareth, Barker, Helena, Cargill, Anne, Eglezos, Anthony, Castellarnau, Alex, Paull, Jeremy R. A. and Hufton, Richard (2023). Abstract A147: a HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging. Molecular Cancer Therapeutics, 22 (12_Supplement), A147-A147. doi: 10.1158/1535-7163.targ-23-a147

Abstract A147: a HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging

2023

Journal Article

Targeted hyperbranched nanoparticles for delivery of doxorubicin in breast cancer brain metastasis

Lim, Malcolm, Fletcher, Nicholas L., Saunus, Jodi M., McCart Reed, Amy E., Chittoory, Haarika, Simpson, Peter T., Thurecht, Kristofer J. and Lakhani, Sunil R. (2023). Targeted hyperbranched nanoparticles for delivery of doxorubicin in breast cancer brain metastasis. Molecular Pharmaceutics, 20 (12), 6169-6183. doi: 10.1021/acs.molpharmaceut.3c00558

Targeted hyperbranched nanoparticles for delivery of doxorubicin in breast cancer brain metastasis

2023

Journal Article

An immunomodulating peptide with potential to suppress tumour growth and autoimmunity

Agrez, Michael, Chandler, Christopher, Thurecht, Kristofer J., Fletcher, Nicholas L., Liu, Feifei, Subramaniam, Gayathri, Howard, Christopher B., Blyth, Benjamin, Parker, Stephen, Turner, Darryl, Rzepecka, Justyna, Knox, Gavin, Nika, Anastasia, Hall, Andrew M., Gooding, Hayley and Gallagher, Laura (2023). An immunomodulating peptide with potential to suppress tumour growth and autoimmunity. Scientific Reports, 13 (1) 19741, 19741. doi: 10.1038/s41598-023-47229-y

An immunomodulating peptide with potential to suppress tumour growth and autoimmunity

2023

Journal Article

Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers

Balaji, Arunpandian, Bell, Craig A., Houston, Zachary H., Bridle, Kim R., Genz, Berit, Fletcher, Nicholas L., Ramm, Grant A. and Thurecht, Kristofer J. (2023). Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers. Biomaterials, 302 122318, 1-18. doi: 10.1016/j.biomaterials.2023.122318

Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers

2023

Journal Article

Click‐on antibody fragments for customisable targeted nanomedicines – site‐specific tetrazine and azide functionalisation through non‐canonical amino acid incorporation

Huda, Pie, Humphries, James, Fletcher, Nicholas L., Howard, Christopher B., Thurecht, Kristofer J. and Bell, Craig A. (2023). Click‐on antibody fragments for customisable targeted nanomedicines – site‐specific tetrazine and azide functionalisation through non‐canonical amino acid incorporation. Chemistry–Methods, 4 (2) e202300036. doi: 10.1002/cmtd.202300036

Click‐on antibody fragments for customisable targeted nanomedicines – site‐specific tetrazine and azide functionalisation through non‐canonical amino acid incorporation

2023

Journal Article

An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage

Agrez, Michael, Rybchyn, Mark Stephen, De Silva, Warusavithana Gunawardena Manori, Mason, Rebecca Sara, Chandler, Christopher, Piva, Terrence J., Thurecht, Kristofer, Fletcher, Nicholas, Liu, Feifei, Subramaniam, Gayathri, Howard, Christopher B., Blyth, Benjamin, Parker, Stephen, Turner, Darryl, Rzepecka, Justyna, Knox, Gavin, Nika, Anastasia, Hall, Andrew, Gooding, Hayley and Gallagher, Laura (2023). An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage. Scientific Reports, 13 (1) 11702, 1-19. doi: 10.1038/s41598-023-38890-4

An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage

2023

Conference Publication

Dox- loaded mpeg nanoparticles as a promising treatment in a humanized mouse model for breast cancer bone metastasis

Frankenbach, Tina, Landgraf, Marietta, Fletcher, Nicholas, Howard, Christopher, Ravichandran, Akhilandeshwari, Akhter, Dewan, Shafiee, Abbas, Holzapfel, Boris M., Thurecht, Kristofer, McGovern, Jacqui and Hutmacher, Dietmar W. (2023). Dox- loaded mpeg nanoparticles as a promising treatment in a humanized mouse model for breast cancer bone metastasis. Tissue Engineering and Regenerative Medicine International Society (TERMIS), Krakow, Poland, 28 June - 1 July 2022. New Rochelle, NY United States: Mary Ann Liebert.

Dox- loaded mpeg nanoparticles as a promising treatment in a humanized mouse model for breast cancer bone metastasis

2023

Journal Article

RAFT polymer–antibody conjugation: squaramide ester chemistry leads to conjugates with a therapeutic anti-EGFR antibody with full retention of activity and increased tumor uptake in vivo

Ardana, Aditya, Ghosh, Saikat, Huda, Pie, Fletcher, Nicholas L., Thurecht, Kristofer J. and Williams, Charlotte C. (2023). RAFT polymer–antibody conjugation: squaramide ester chemistry leads to conjugates with a therapeutic anti-EGFR antibody with full retention of activity and increased tumor uptake in vivo. Molecular Pharmaceutics, 20 (6), 3073-3087. doi: 10.1021/acs.molpharmaceut.3c00085

RAFT polymer–antibody conjugation: squaramide ester chemistry leads to conjugates with a therapeutic anti-EGFR antibody with full retention of activity and increased tumor uptake in vivo

2023

Journal Article

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia

Moles, Ernest, Howard, Christopher B., Huda, Pie, Karsa, Mawar, McCalmont, Hannah, Kimpton, Kathleen, Duly, Alastair, Chen, Yongjuan, Huang, Yizhou, Tursky, Melinda L., Ma, David, Bustamante, Sonia, Pickford, Russell, Connerty, Patrick, Omari, Sofia, Jolly, Christopher J., Joshi, Swapna, Shen, Sylvie, Pimanda, John E., Dolnikov, Alla, Cheung, Laurence C., Kotecha, Rishi S., Norris, Murray D., Haber, Michelle, de Bock, Charles E., Somers, Klaartje, Lock, Richard B., Thurecht, Kristofer J. and Kavallaris, Maria (2023). Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. Science Translational Medicine, 15 (696) abm1262, 1-17. doi: 10.1126/scitranslmed.abm1262

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia

2023

Journal Article

Development and validation of a targeted treatment for brain tumors using a multi-drug loaded, relapse-resistant polymeric theranostic

Chu, Weijing, Houston, Zachary H., Fletcher, Nicholas L., Huda, Pie, Ahamed, Muneer, Lim, Ting Xiang, Day, Bryan W., Pinkham, Mark and Thurecht, Kristofer J. (2023). Development and validation of a targeted treatment for brain tumors using a multi-drug loaded, relapse-resistant polymeric theranostic. Biomacromolecules, 24 (6), 2674-2690. doi: 10.1021/acs.biomac.3c00138

Development and validation of a targeted treatment for brain tumors using a multi-drug loaded, relapse-resistant polymeric theranostic

2023

Journal Article

Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma

Janjua, Taskeen Iqbal, Cao, Yuxue, Ahmed-Cox, Aria, Raza, Aun, Moniruzzaman, Md, Akhter, Dewan Taslima, Fletcher, Nicholas L., Kavallaris, Maria, Thurecht, Kristofer J. and Popat, Amirali (2023). Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma. Journal of Controlled Release, 357, 161-174. doi: 10.1016/j.jconrel.2023.03.040

Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma

2023

Journal Article

Combination of chemotherapy and mild hyperthermia using targeted nanoparticles: a potential treatment modality for breast cancer

Kaur, Ishdeep, Tieu, Terence, Deepagan, Veerasikku G., Ali, Muhammad A., Alsunaydih, Fahad, Rudd, David, Moghaddam, Maliheh A., Bourgeois, Laure, Adams, Timothy E., Thurecht, Kristofer J., Yuce, Mehmet, Cifuentes-Rius, Anna and Voelcker, Nicolas H. (2023). Combination of chemotherapy and mild hyperthermia using targeted nanoparticles: a potential treatment modality for breast cancer. Pharmaceutics, 15 (5) 1389, 1-23. doi: 10.3390/pharmaceutics15051389

Combination of chemotherapy and mild hyperthermia using targeted nanoparticles: a potential treatment modality for breast cancer

2023

Journal Article

Homochiral poly(2‐oxazoline)‐based membrane for efficient enantioselective separation

Wang, Fanmengjing, Pizzi, David, Lu, Yizhihao, He, Kaiqiang, Thurecht, Kristofer J., Hill, Matthew R., Marriott, Philip, Holl, Mark M. Banaszak, Kempe, Kristian and Wang, Huanting (2023). Homochiral poly(2‐oxazoline)‐based membrane for efficient enantioselective separation. Angewandte Chemie International Edition, 62 (8) e202212139, 1-6. doi: 10.1002/anie.202212139

Homochiral poly(2‐oxazoline)‐based membrane for efficient enantioselective separation

2023

Journal Article

Pharmacokinetics and Biodistribution of Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma

Ghosh, Saikat, Fletcher, Nicholas L., Huda, Pie, Houston, Zachary H., Howard, Christopher B., Lund, Maria E., Lu, Yanling, Campbell, Douglas H., Walsh, Bradley J. and Thurecht, Kristofer J. (2023). Pharmacokinetics and Biodistribution of Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular pharmaceutics, 20 (3), 1549-1563. doi: 10.1021/acs.molpharmaceut.2c00760

Pharmacokinetics and Biodistribution of Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma

2023

Journal Article

Enhanced drug delivery to cancer cells through a pH-sensitive polycarbonate platform

Arno, Maria C., Simpson, Joshua D., Blackman, Lewis D., Brannigan, Ruairí P., Thurecht, Kristofer J. and Dove, Andrew P. (2023). Enhanced drug delivery to cancer cells through a pH-sensitive polycarbonate platform. Biomaterials Science, 11 (3), 908-915. doi: 10.1039/d2bm01626e

Enhanced drug delivery to cancer cells through a pH-sensitive polycarbonate platform

2022

Journal Article

Utilizing PET and MALDI imaging for discovery of a targeted probe for brain endocannabinoid α/β-hydrolase domain 6 (ABHD6)

Mardon, Karine, Patel, Jayendra Z., Savinainen, Juha R., Stimson, Damion H. R., Oyagawa, Caitlin R. M., Grimsey, Natasha L., Migotto, Mary-anne, Njiru, Grace F. M., Hamilton, Brett R., Cowin, Gary, Yli-Kauhaluoma, Jari, Vanduffel, Wim, Blakey, Idriss, Bhalla, Rajiv, Cawthorne, Christopher, Celen, Sofie, Bormans, Guy, Thurecht, Kristofer J and Ahamed, Muneer (2022). Utilizing PET and MALDI imaging for discovery of a targeted probe for brain endocannabinoid α/β-hydrolase domain 6 (ABHD6). Journal of Medicinal Chemistry, 66 (1), 538-552. doi: 10.1021/acs.jmedchem.2c01485

Utilizing PET and MALDI imaging for discovery of a targeted probe for brain endocannabinoid α/β-hydrolase domain 6 (ABHD6)

2022

Journal Article

Probing the biocompatibility and immune cell association of chiral, water-soluble, bottlebrush poly(2-oxazoline)s

Pizzi, David, Humphries, James, Morrow, Joshua P., Mahmoud, Ayaat M., Fletcher, Nicholas L., Sonderegger, Stefan E., Bell, Craig A., Thurecht, Kristofer J. and Kempe, Kristian (2022). Probing the biocompatibility and immune cell association of chiral, water-soluble, bottlebrush poly(2-oxazoline)s. Biomacromolecules, 24 (1), 246-257. doi: 10.1021/acs.biomac.2c01105

Probing the biocompatibility and immune cell association of chiral, water-soluble, bottlebrush poly(2-oxazoline)s

2022

Journal Article

Modulating macrophage clearance of nanoparticles: comparison of small-molecule and biologic drugs as pharmacokinetic modifiers of soft nanomaterials

Mills, Jessica A., Humphries, James, Simpson, Joshua D., Sonderegger, Stefan E., Thurecht, Kristofer J. and Fletcher, Nicholas L. (2022). Modulating macrophage clearance of nanoparticles: comparison of small-molecule and biologic drugs as pharmacokinetic modifiers of soft nanomaterials. Molecular Pharmaceutics, 19 (11), 4080-4097. doi: 10.1021/acs.molpharmaceut.2c00528

Modulating macrophage clearance of nanoparticles: comparison of small-molecule and biologic drugs as pharmacokinetic modifiers of soft nanomaterials

2022

Journal Article

Modeling brain metastasis by internal carotid artery injection of cancer cells

Lim, Malcolm, Fletcher, Nicholas, Reed, Amy Mccart, Flint, Melanie, Thurecht, Kristofer, Saunus, Jodi and Lakhani, Sunil R. (2022). Modeling brain metastasis by internal carotid artery injection of cancer cells. Journal of Visualized Experiments, 2022 (186) e64216. doi: 10.3791/64216

Modeling brain metastasis by internal carotid artery injection of cancer cells

2022

Journal Article

Protected amine-functional initiators for the synthesis of α-amine homo- and heterotelechelic poly(2-ethyl-2-oxazoline)s

Mazrad, Zihnil A. I., Lai, May, Davis, Thomas P., Nicolazzo, Joseph A., Thurecht, Kristofer J., Leiske, Meike N. and Kempe, Kristian (2022). Protected amine-functional initiators for the synthesis of α-amine homo- and heterotelechelic poly(2-ethyl-2-oxazoline)s. Polymer Chemistry, 13 (30), 4436-4445. doi: 10.1039/d2py00649a

Protected amine-functional initiators for the synthesis of α-amine homo- and heterotelechelic poly(2-ethyl-2-oxazoline)s

Current funding

  • 2024 - 2027
    Hybrid quantum sensors for rapid detection of chemical and biochemical agents as a tool to mitigate the risks of terrorist attacks
    Quantum 2032 Challenge Program
    Open grant
  • 2024 - 2026
    Advancing the delivery of gene therapy to motor neurons and glial cells using focused ultrasound (NHMRC Ideas grant administered by University of Wollongong)
    University of Wollongong
    Open grant
  • 2024 - 2028
    Nanoparticle gene therapy for cystic fibrosis
    NHMRC MRFF PPHR - Chronic Respiratory Conditions
    Open grant
  • 2024 - 2026
    Reset rheumatoid arthritis (RESET RA)
    MRFF Frontier Health and Medical Research Program administered by AusIndustry
    Open grant
  • 2024 - 2025
    Targeting brain tumour using rationally designed nanomedicine
    Brain Foundation Research Grant
    Open grant
  • 2024 - 2026
    Developing novel peptide tracers for improving immunotherapy outcomes
    NHMRC Development Grant
    Open grant
  • 2024 - 2027
    Understanding production and application of alpha emitting radionuclides
    ARC Linkage Projects
    Open grant
  • 2023 - 2028
    ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
    ARC Industrial Transformation Research Hubs
    Open grant
  • 2023 - 2025
    Overcome biological barriers in cancer for the treatment of glioblastoma using personalised nanomedicine
    TdC Pioneering Grant
    Open grant
  • 2023 - 2027
    Advancing the treatment of brain cancer in children (UNSW led NHMRC Synergy Grant)
    University of New South Wales
    Open grant
  • 2022 - 2025
    Establishing Design Principles of Polymers for Intracellular Delivery (UWA led ARC Discovery Project)
    University of Western Australia
    Open grant

Past funding

  • 2024
    Radiolabelling of proprietary Clarity bispecific chelators with Ac-225
    Clarity Pharmaceuticals Pty Ltd
    Open grant
  • 2023 - 2024
    High-Resolution Electron Paramagnetic Resonance Imaging and Spectroscopy
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2022 - 2023
    Project KT2022-11: Evaluate biodistribution of PET-labelled EV following various administration routes
    Exopharm
    Open grant
  • 2022 - 2024
    Enhancing delivery of gene therapy to motor neurons and glial cells using focused ultrasound (FightMND Impact Grant administered by University of Wollongong)
    University of Wollongong
    Open grant
  • 2021 - 2024
    Antigen-specific immunotherapy with proinsulin33-63/calcitriol liposomes in type 1 diabetes
    The Leona M. and Harry B. Helmsley Charitable Trust
    Open grant
  • 2021 - 2024
    Innovative delivery methods for the biologic soluble RAGE to prevent Type 1 Diabetes
    JDRF Pilot and Innovation Awards
    Open grant
  • 2021 - 2022
    Nuclear medicine for the future: Targeted radiometal therapeutics for oncology
    IPF Healthy - Medical Research
    Open grant
  • 2021 - 2023
    ACRF Facility for Targeted Radiometals in Cancer (AFTRiC)
    Australian Cancer Research Foundation
    Open grant
  • 2020 - 2021
    Non-invasive drug delivery across the blood brain barrier: Improving the bioavailability of drugs for MND (MNDRIA grant administered by The University of Wollongong)
    University of Wollongong
    Open grant
  • 2019 - 2022
    Smart affinity membranes for manufacture of high value therapeutic proteins
    ARC Linkage Projects
    Open grant
  • 2019
    Advanced Nanoparticle, Colloid and Microparticle Characterisation and Precision Engineering Nanosystems Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    Dissolution DNP Hyperpolariser
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2019
    Imaging Mass Spectrometry at Higher Mass Resolution
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2018
    Biomolecular Imager and microscope for preclinical radiopharmaceutical development
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018
    Continuous chromatography system for advanced bioprocessing
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018
    In vivo optical imaging into the next generation
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2018 - 2021
    Next generation imaging to bridge the knowledge gap in nanomedicine delivery
    NHMRC Career Development Fellowship
    Open grant
  • 2017 - 2024
    ARC Training Centre for Innovation in Biomedical Imaging Technology
    ARC Industrial Transformation Training Centres
    Open grant
  • 2017
    Lattice light sheet microscopy for imaging biology in real space and time
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2016
    Analyse the biodistribution of Cy-5 labelled IK14004 and IK14800
    Inter-K Pty Limited
    Open grant
  • 2016 - 2017
    EGFR targeted nanoparticle feasibility study
    Samyang Biopharmaceuticals Corporation
    Open grant
  • 2016 - 2017
    Radiosensitization of prostate cancer by nanoparticle mediated siRNA delivery
    RANZCR Research Grant
    Open grant
  • 2016 - 2019
    Next generation hybrid nanomaterials: bispecific antibody-targeted polymers
    ARC Linkage Projects
    Open grant
  • 2016 - 2017
    Facility for characterisation of bionanomaterials
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2016
    Exosome and Bio/Nanoparticle Characterisation Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2018
    Immuno-polymeric drugs for prostate cancer therapy
    NHMRC Project Grant
    Open grant
  • 2015 - 2022
    ACRF Facility for Molecular Imaging Agents in Cancer (AFMIAC)
    Australian Cancer Research Foundation
    Open grant
  • 2015 - 2016
    The Vevo 2100 micro-ultrasound plus LAZR photoacoustic imaging platform (ARC LIEF project administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2015 - 2016
    Developing targeted EphA2 based imaging technology for glioblastoma
    Cure Brain Cancer Foundation
    Open grant
  • 2014
    Asia-China Young Scientists Exchange Programme
    Australia-China Science and Research Fund
    Open grant
  • 2014 - 2021
    ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (Monash lead institution)
    Monash University
    Open grant
  • 2014 - 2016
    Detection and treatment of triple negative breast cancer: development of novel nanomedicine devices allowing simultaneous molecular imaging, gene therapy and aptamer therapy
    National Breast Cancer Foundation Novel Concept Award
    Open grant
  • 2014 - 2015
    Development of a rapid ex vivo screening assay for immunotoxicity of nanoparticles
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2014 - 2016
    Multifunctional and Multimodal Theranostics: Manipulating Material Properties for Advanced Diagnostics
    ARC Discovery Projects
    Open grant
  • 2013 - 2015
    Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics (NHMRC Project Grant administered by the Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2012
    Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics
    Queensland University of Technology
    Open grant
  • 2012 - 2015
    Traceable Theranostics: Tools for visualising drug delivery and therapeutic benefit in vivo
    ARC Future Fellowships
    Open grant
  • 2011 - 2012
    Green biopolymer nanocomposites facility: supercritical carbon dioxide characterisation and processing for nanomaterials and biopolymers
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2011
    Detection platform for both radiometyricand non-radiometric labels
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011
    Development of PET/MRI multimodal biomedical imaging agents
    Australian Institute of Nuclear Science and Engineering
    Open grant
  • 2011
    ResTeach 2011 0.1 FTE School of Pharmacy
    Open grant
  • 2010 - 2011
    Hyperbranched Polymer:siRNA Conjugates: Advanced Polymeric Carriers for Cancer Therapy
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2010 - 2013
    Novel polymeric microparticles for slow-release intrathecal delivery of analgesics
    ARC Linkage Projects
    Open grant
  • 2010
    A new portable molecular imaging modality - dynamic nuclear polarization
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Hyperbranched Ploymers for Targeted Drug Delivery: Synthesis, Properties and Molecular Conjugation
    UQ Early Career Researcher
    Open grant
  • 2010 - 2012
    Multimodal biomedical imaging probes: development of advanced polymer nanocomposite devices for oncology
    ARC Discovery Projects
    Open grant
  • 2009 - 2010
    Biocatalytic Polymerisation in Supercritical CO2
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2008 - 2011
    Supercritical CO2: A Clean, Green Reaction Medium for Novel Polymer Synthesis and Modification
    ARC Discovery Projects
    Open grant

Availability

Professor Kristofer Thurecht is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Targeted multifunctional nanoparticles for radiation-enhanced cancer therapy

    Principal Advisor

    Other advisors: Dr Gayathri Ediriweera

  • Doctor Philosophy

    Development of novel gene therapy strategies for treating brain cancer

    Principal Advisor

    Other advisors: Dr James Humphries

  • Doctor Philosophy

    Targeted polymeric radiopharmaceutical as cancer theranostics

    Principal Advisor

    Other advisors: Dr Nick Fletcher

  • Doctor Philosophy

    Molecular alpha radiotherapy using nanomaterials mediated via pre-targeting strategy

    Principal Advisor

    Other advisors: Dr Nick Fletcher, Dr James Wood

  • Doctor Philosophy

    Development of novel polymer-protein conjugates

    Principal Advisor

    Other advisors: Dr Craig Bell, Associate Professor Idriss Blakey

  • Doctor Philosophy

    Novel complementary diagnostics for improved therapeutics/theranostics

    Principal Advisor

    Other advisors: Dr Craig Bell, Dr Nick Fletcher, Dr Rhia Stone

  • Doctor Philosophy

    Utilising Molecular Imaging to Understand Nanomedicine Behaviours

    Principal Advisor

    Other advisors: Associate Professor Idriss Blakey

  • Doctor Philosophy

    Novel complementary diagnostics for improved therapeutics/theranostics

    Principal Advisor

    Other advisors: Dr Craig Bell, Dr Nick Fletcher, Dr Rhia Stone

  • Master Philosophy

    Development and characterization of bispecific and bivalent nanobodies for targeting ErBb receptors

    Principal Advisor

    Other advisors: Dr Jodi Saunus, Dr Nick Fletcher, Dr Pie Huda

  • Doctor Philosophy

    Development of site-specific radiopharmaceuticals using nanotechnology

    Principal Advisor

    Other advisors: Dr Craig Bell, Dr Nick Fletcher, Dr James Humphries

  • Doctor Philosophy

    Aqueous one-pot photoinitiated polymerization-induced self-assembly (photo-PISA) to synthesize therapeutic protein loaded nanocarriers

    Principal Advisor

    Other advisors: Dr Craig Bell, Dr Gayathri Ediriweera

  • Doctor Philosophy

    Development of polymeric nanoparticles for monitoring cytokine release in vivo via FRET

    Principal Advisor

    Other advisors: Dr Craig Bell, Associate Professor Idriss Blakey

  • Doctor Philosophy

    The effect of avidity on nanobody-based formats for theranostic applications

    Principal Advisor

    Other advisors: Dr Jodi Saunus, Dr Nick Fletcher, Dr Pie Huda

  • Doctor Philosophy

    Development of polymeric nanoparticles for monitoring cytokine release in vivo via FRET

    Principal Advisor

    Other advisors: Dr Craig Bell, Associate Professor Idriss Blakey

  • Doctor Philosophy

    Nanoparticle therapy to improve brain outcomes in growth restricted newborns

    Principal Advisor

  • Doctor Philosophy

    Development of novel polymer-protein conjugates

    Principal Advisor

    Other advisors: Dr Craig Bell, Associate Professor Idriss Blakey

  • Doctor Philosophy

    Design of a complex in vitro microfluidic device for the evaluation of polymeric nanoparticles

    Principal Advisor

    Other advisors: Dr Nick Fletcher

  • Doctor Philosophy

    Development of novel nanoparticles for enhanced radiotherapeutic efficacy

    Principal Advisor

    Other advisors: Dr Nick Fletcher

  • Doctor Philosophy

    Modulating the Mononuclear Phagocyte System for Improved Nanomaterial Delivery

    Associate Advisor

    Other advisors: Associate Professor Barbara Rolfe, Dr Nick Fletcher

  • Doctor Philosophy

    Seeing the Unseen: Imaging Bacterial Infections

    Associate Advisor

    Other advisors: Professor Mark Blaskovich, Dr Rhia Stone

  • Doctor Philosophy

    Targeted Alpha Therapies and Biological Responses: Improving Prognostic Power and Regimen Design

    Associate Advisor

    Other advisors: Dr Nick Fletcher

  • Doctor Philosophy

    Inhalable nanoparticle-based gene delivery system for cystic fibrosis

    Associate Advisor

    Other advisors: Dr Neville Butcher, Associate Professor Lisa Kaminskas

  • Doctor Philosophy

    Development of Novel Agents for PFAS Monitoring and Removal from Contaminated Sources

    Associate Advisor

    Other advisors: Dr Cheng Zhang

  • Doctor Philosophy

    Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices

    Associate Advisor

    Other advisors: Dr Matthew Roberts, Dr Nick Rukin

  • Master Philosophy

    High Activity Automated Synthesis of [68Ga]Ga-DOTA-TATE for Improved Clinical Workflow

    Associate Advisor

  • Doctor Philosophy

    Seeing the Unseen: Imaging Bacterial Infections

    Associate Advisor

    Other advisors: Professor Mark Blaskovich, Dr Rhia Stone

  • Doctor Philosophy

    Understanding the function of CDCP1 and its potential as a theranostic target for cholangiocarcinoma

    Associate Advisor

Completed supervision

Enquiries

Contact Professor Kristofer Thurecht directly for media enquiries about:

  • Nanomedicine polymer therapeutics
  • physical chemistry
  • Polymer
  • Polymer chemistry
  • Polymeric imaging agents

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au